Header Logo

Doreen Brettler

Concepts (320)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
49
2014
56
2.610
Why?
Factor VIII
23
2014
31
1.190
Why?
HIV Seropositivity
17
1995
82
0.520
Why?
Lymphoma, Mantle-Cell
1
2015
12
0.490
Why?
Acquired Immunodeficiency Syndrome
11
1996
137
0.370
Why?
Blood Coagulation Factors
4
1996
13
0.340
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2008
39
0.300
Why?
Hodgkin Disease
1
2008
55
0.300
Why?
Cell Transformation, Neoplastic
1
2008
193
0.280
Why?
Leukocyte Count
9
2015
97
0.250
Why?
HIV
6
1998
68
0.240
Why?
Isoantibodies
2
1996
33
0.230
Why?
Hepatitis C
6
1995
143
0.220
Why?
HIV-1
8
1999
692
0.210
Why?
Sexual Behavior
2
1992
189
0.180
Why?
Humans
67
2015
59106
0.180
Why?
HIV Infections
10
1999
912
0.180
Why?
Recombinant Fusion Proteins
2
2011
488
0.160
Why?
Male
36
2015
27623
0.160
Why?
Genetic Therapy
2
2005
733
0.160
Why?
Transfusion Reaction
4
1992
44
0.150
Why?
Home Infusion Therapy
2
2001
7
0.150
Why?
Immunoglobulin G
3
2014
444
0.150
Why?
Surgical Procedures, Operative
2
1996
137
0.150
Why?
Professional Staff Committees
1
1997
5
0.140
Why?
HIV Antibodies
4
1994
133
0.140
Why?
Malaria Vaccines
1
1997
27
0.140
Why?
Hemorrhage
3
2001
258
0.140
Why?
Vaccines, Synthetic
1
1997
67
0.140
Why?
Clinical Trials as Topic
3
1997
441
0.130
Why?
Factor IX
5
2000
7
0.130
Why?
Child, Preschool
13
2001
1779
0.130
Why?
Hemostasis
1
1996
18
0.130
Why?
Anterior Cruciate Ligament
1
1995
13
0.120
Why?
Leukapheresis
1
2015
8
0.120
Why?
Zidovudine
2
1994
12
0.120
Why?
Pregnancy Complications, Neoplastic
1
2015
11
0.120
Why?
Diverticulitis
1
2015
28
0.120
Why?
Cysts
1
1995
40
0.120
Why?
Adult
29
2015
15615
0.120
Why?
Autoantibodies
2
2014
171
0.120
Why?
Fluorescence Polarization Immunoassay
1
2014
8
0.120
Why?
Arthroplasty
1
1994
4
0.120
Why?
Child
19
2001
4168
0.120
Why?
Hepatitis Antibodies
3
1992
6
0.120
Why?
Sexual Partners
3
1991
75
0.120
Why?
Menisci, Tibial
1
1994
24
0.120
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2015
67
0.120
Why?
Spectrometry, Fluorescence
1
2014
90
0.120
Why?
Proto-Oncogene Proteins c-ets
2
2011
19
0.110
Why?
T-Lymphocytes, Cytotoxic
6
1999
168
0.110
Why?
Hemophilia B
3
1996
4
0.110
Why?
Hepatitis, Viral, Human
2
1990
10
0.110
Why?
Immune Tolerance
3
1993
172
0.110
Why?
Immunophenotyping
3
2009
184
0.100
Why?
Comprehensive Health Care
1
1993
17
0.100
Why?
Adolescent
16
2014
5816
0.100
Why?
T-Lymphocyte Subsets
1
1994
244
0.100
Why?
Knee Joint
3
1995
285
0.100
Why?
Repressor Proteins
2
2011
332
0.100
Why?
Myeloproliferative Disorders
1
2011
15
0.090
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2011
13
0.090
Why?
Hypersensitivity, Delayed
3
1987
19
0.090
Why?
Aged, 80 and over
4
2015
5101
0.090
Why?
Growth Disorders
1
1990
28
0.090
Why?
Antigens
2
1996
146
0.080
Why?
Leukemia, Myeloid, Chronic-Phase
1
2009
5
0.080
Why?
Basophils
1
2009
14
0.080
Why?
ZAP-70 Protein-Tyrosine Kinase
1
2008
5
0.080
Why?
Postoperative Complications
1
1995
1184
0.080
Why?
Family Planning Services
1
1988
21
0.080
Why?
Antibodies
1
1989
179
0.080
Why?
Immune System
1
1989
129
0.080
Why?
Lymph Nodes
1
2008
214
0.070
Why?
Enzyme-Linked Immunosorbent Assay
4
1992
444
0.070
Why?
Aged
11
2008
13348
0.070
Why?
Antibodies, Monoclonal
3
1992
836
0.070
Why?
Middle Aged
16
2011
16240
0.060
Why?
Infant
7
2001
1482
0.060
Why?
Hemarthrosis
1
1985
3
0.060
Why?
Antibody Formation
3
2000
108
0.060
Why?
Joint Diseases
1
1985
18
0.060
Why?
HIV Seronegativity
2
1994
18
0.060
Why?
Genes, nef
2
1995
6
0.060
Why?
Recombinant Proteins
6
2000
688
0.060
Why?
Polymerase Chain Reaction
5
1999
495
0.050
Why?
T-Lymphocytes, Helper-Inducer
4
1991
109
0.050
Why?
Risk Factors
6
2001
4948
0.050
Why?
Age Factors
1
2005
1499
0.050
Why?
Multicenter Studies as Topic
3
1991
130
0.050
Why?
Pregnancy
3
2015
2202
0.040
Why?
Antibodies, Viral
4
1987
291
0.040
Why?
Female
11
2015
30613
0.040
Why?
HIV Long-Term Survivors
1
1999
8
0.040
Why?
Prospective Studies
7
1996
3052
0.040
Why?
Follow-Up Studies
4
1994
2330
0.040
Why?
Cohort Studies
5
2001
2367
0.040
Why?
Wounds, Gunshot
1
1979
51
0.040
Why?
Gene Products, gag
3
1997
63
0.040
Why?
Time Factors
3
2014
3586
0.040
Why?
Risk Assessment
1
2005
1898
0.040
Why?
DNA, Viral
3
1995
223
0.040
Why?
Hypohidrosis
1
1998
3
0.040
Why?
Lymphoma, T-Cell
1
1998
22
0.040
Why?
Alopecia
1
1998
25
0.040
Why?
Sweat Gland Neoplasms
1
1998
20
0.040
Why?
Pruritus
1
1998
29
0.040
Why?
Sjogren's Syndrome
1
1998
24
0.040
Why?
Fractures, Bone
1
1979
135
0.040
Why?
Semen
1
1998
42
0.040
Why?
Leukocytes
1
1998
97
0.040
Why?
Blood Transfusion
4
1992
149
0.030
Why?
T-Lymphocytes
3
1999
982
0.030
Why?
Lymphoma, AIDS-Related
1
1996
7
0.030
Why?
Desensitization, Immunologic
1
1996
9
0.030
Why?
Contraindications
1
1996
44
0.030
Why?
Global Health
2
1995
167
0.030
Why?
Lymphoma, Non-Hodgkin
1
1996
50
0.030
Why?
Treatment Outcome
2
2005
5227
0.030
Why?
Immunization
1
1996
127
0.030
Why?
Anaphylaxis
1
1996
40
0.030
Why?
Martial Arts
1
1995
1
0.030
Why?
Patella
1
1995
13
0.030
Why?
Factor VII
2
1992
3
0.030
Why?
CD4-Positive T-Lymphocytes
3
1994
620
0.030
Why?
Species Specificity
1
1996
328
0.030
Why?
Tendons
1
1995
23
0.030
Why?
Bone Transplantation
1
1995
24
0.030
Why?
Live Birth
1
2015
20
0.030
Why?
Pulmonary Ventilation
1
2015
37
0.030
Why?
Anterior Cruciate Ligament Injuries
1
1995
26
0.030
Why?
Bone Resorption
1
1995
41
0.030
Why?
Swine
1
1996
350
0.030
Why?
Transplantation, Autologous
1
1995
119
0.030
Why?
Reference Values
2
1992
326
0.030
Why?
HIV Antigens
2
1991
18
0.030
Why?
HIV Core Protein p24
2
1991
17
0.030
Why?
Tibia
1
1995
68
0.030
Why?
Rupture, Spontaneous
1
1994
22
0.030
Why?
Knee Injuries
1
1995
47
0.030
Why?
Arthroscopy
1
1994
24
0.030
Why?
Patient Selection
1
1997
458
0.030
Why?
von Willebrand Diseases
2
1992
4
0.030
Why?
Dyspnea
1
2015
116
0.030
Why?
Osteotomy
1
1994
14
0.030
Why?
Blotting, Western
2
1992
582
0.030
Why?
Cesarean Section
1
2015
95
0.030
Why?
Terminology as Topic
1
1994
129
0.030
Why?
Hospitalization
1
2001
1288
0.030
Why?
Gene Deletion
1
1995
292
0.030
Why?
Radiography
1
1995
515
0.030
Why?
Lymphocyte Activation
3
1999
743
0.030
Why?
Hepatitis B
3
1992
28
0.030
Why?
Blood Donors
2
1990
22
0.030
Why?
Drug Contamination
2
1990
15
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
2
1991
105
0.030
Why?
Skin Neoplasms
1
1998
403
0.030
Why?
Gene Products, nef
1
1992
13
0.030
Why?
Lymphocyte Subsets
1
1992
36
0.030
Why?
nef Gene Products, Human Immunodeficiency Virus
1
1992
24
0.030
Why?
CD4 Antigens
2
1991
148
0.030
Why?
Prevalence
3
1992
1250
0.030
Why?
Factor VII Deficiency
1
1992
1
0.020
Why?
Factor VIIIa
1
1992
1
0.020
Why?
Factor IXa
1
1992
1
0.020
Why?
Factor X
1
1992
2
0.020
Why?
Prothrombin
1
1992
3
0.020
Why?
Factor VIIa
1
1992
3
0.020
Why?
Skin Tests
3
1986
21
0.020
Why?
Prenatal Diagnosis
2
1992
38
0.020
Why?
Blood Coagulation
1
1992
37
0.020
Why?
Predictive Value of Tests
1
2014
1022
0.020
Why?
AIDS-Related Complex
1
1991
3
0.020
Why?
Imatinib Mesylate
1
2011
33
0.020
Why?
Placebos
1
1991
68
0.020
Why?
Herpesviridae Infections
3
1986
25
0.020
Why?
Benzamides
1
2011
63
0.020
Why?
Piperazines
1
2011
74
0.020
Why?
HTLV-I Antibodies
1
1990
2
0.020
Why?
Virus Diseases
1
1992
114
0.020
Why?
Immunologic Techniques
1
1990
12
0.020
Why?
Growth
1
1990
22
0.020
Why?
Pedigree
1
1991
183
0.020
Why?
Virus Replication
3
1999
304
0.020
Why?
Pyrimidines
1
2011
129
0.020
Why?
T-Lymphocytes, Regulatory
3
1987
207
0.020
Why?
Prognosis
1
2014
1593
0.020
Why?
Risk
2
1988
364
0.020
Why?
Pregnancy Outcome
1
1991
181
0.020
Why?
Viral Proteins
1
1991
252
0.020
Why?
Carcinoma, Hepatocellular
1
1991
168
0.020
Why?
Immunity, Cellular
2
1989
169
0.020
Why?
Chromosomes, Human, Pair 12
1
2009
9
0.020
Why?
Chromosomes, Human, Pair 5
1
2009
8
0.020
Why?
Biomarkers
1
2014
1304
0.020
Why?
Antigen-Antibody Complex
1
1989
50
0.020
Why?
Half-Life
1
1989
74
0.020
Why?
Gene Rearrangement
1
2009
38
0.020
Why?
Herpesvirus 4, Human
3
1986
178
0.020
Why?
Translocation, Genetic
1
2009
63
0.020
Why?
Immunoglobulin E
1
1989
86
0.020
Why?
In Situ Hybridization, Fluorescence
1
2009
152
0.020
Why?
CD4 Lymphocyte Count
2
1999
90
0.020
Why?
Clinical Protocols
1
1989
135
0.020
Why?
Liver Neoplasms
1
1991
277
0.020
Why?
CD8 Antigens
3
1994
53
0.020
Why?
Deltaretrovirus
2
1986
2
0.020
Why?
Bone Marrow Cells
1
2009
231
0.020
Why?
Histocompatibility Antigens Class I
1
1989
132
0.020
Why?
Fluorescent Antibody Technique
1
1988
216
0.020
Why?
New England
1
1988
262
0.020
Why?
Dermatitis, Contact
1
1987
12
0.020
Why?
Flow Cytometry
1
2009
638
0.020
Why?
Hypertension, Pulmonary
1
1988
91
0.020
Why?
Cytomegalovirus
2
1986
90
0.020
Why?
Socioeconomic Factors
1
1988
741
0.020
Why?
Antineoplastic Agents
1
2011
629
0.020
Why?
Cell Nucleus
1
2009
605
0.020
Why?
Hepatitis B Antigens
1
1985
5
0.020
Why?
Animals
2
1996
19589
0.020
Why?
Young Adult
1
2014
4250
0.010
Why?
Motion
1
1985
56
0.010
Why?
Long-Term Care
1
1985
176
0.010
Why?
Longitudinal Studies
1
1987
1189
0.010
Why?
Cytomegalovirus Infections
3
1992
66
0.010
Why?
World Health Organization
2
1995
30
0.010
Why?
Molecular Sequence Data
2
1998
1948
0.010
Why?
Virus Cultivation
2
1994
17
0.010
Why?
Developing Countries
2
1995
85
0.010
Why?
Receptors, Drug
1
1982
5
0.010
Why?
NADH, NADPH Oxidoreductases
1
1982
18
0.010
Why?
Protein Kinase C
1
1982
98
0.010
Why?
Antigens, Viral
3
1987
129
0.010
Why?
Surveys and Questionnaires
1
1988
2509
0.010
Why?
Cytotoxicity Tests, Immunologic
2
1991
29
0.010
Why?
Receptors, Chemokine
1
1999
36
0.010
Why?
United States
2
1990
7370
0.010
Why?
Population Surveillance
1
2001
194
0.010
Why?
Neutrophils
1
1982
353
0.010
Why?
Chemokines
1
1999
92
0.010
Why?
Polymorphism, Genetic
1
1999
185
0.010
Why?
Extremities
1
1979
46
0.010
Why?
Viral Load
1
1999
219
0.010
Why?
Disease Reservoirs
1
1998
9
0.010
Why?
Substance-Related Disorders
1
1985
682
0.010
Why?
Caenorhabditis elegans Proteins
1
1982
397
0.010
Why?
HIV Protease Inhibitors
1
1998
105
0.010
Why?
Phylogeny
1
1998
336
0.010
Why?
RNA, Viral
1
1998
259
0.010
Why?
HIV Protease
1
1998
120
0.010
Why?
AIDS-Related Opportunistic Infections
1
1996
68
0.010
Why?
Genetic Variation
1
1998
357
0.010
Why?
Mice
1
1989
10247
0.010
Why?
Consumer Product Safety
1
1995
12
0.010
Why?
Developed Countries
1
1995
16
0.010
Why?
Amino Acid Sequence
1
1998
1552
0.010
Why?
Antibody-Dependent Cell Cytotoxicity
1
1994
26
0.010
Why?
beta 2-Microglobulin
1
1994
48
0.010
Why?
Viremia
1
1994
44
0.010
Why?
Primary Prevention
1
1995
134
0.010
Why?
Genes, gag
1
1993
11
0.010
Why?
Formaldehyde
1
1993
32
0.010
Why?
Histological Techniques
1
1993
18
0.010
Why?
Safety
1
1993
141
0.010
Why?
Base Sequence
1
1995
1299
0.010
Why?
Genetic Carrier Screening
1
1992
14
0.010
Why?
Genetic Counseling
1
1992
15
0.010
Why?
Fetal Diseases
1
1992
21
0.010
Why?
Maternal-Fetal Exchange
1
1991
28
0.010
Why?
International Cooperation
1
1992
84
0.010
Why?
gag Gene Products, Human Immunodeficiency Virus
1
1991
35
0.010
Why?
Viral Core Proteins
1
1991
30
0.010
Why?
Protein Precursors
1
1991
75
0.010
Why?
Hot Temperature
1
1992
126
0.010
Why?
Pregnancy Complications, Infectious
1
1991
60
0.010
Why?
Cytotoxicity, Immunologic
1
1991
144
0.010
Why?
Metabolic Clearance Rate
1
1990
47
0.010
Why?
Hemostasis, Surgical
1
1990
17
0.010
Why?
HTLV-I Infections
1
1990
3
0.010
Why?
France
1
1990
13
0.010
Why?
Blood Loss, Surgical
1
1990
56
0.010
Why?
Clinical Enzyme Tests
1
1990
12
0.010
Why?
Alanine Transaminase
1
1990
38
0.010
Why?
Serologic Tests
1
1990
34
0.010
Why?
Disease Progression
1
1995
1120
0.010
Why?
Health Education
1
1992
182
0.010
Why?
Phenotype
1
1994
1134
0.010
Why?
Peptide Fragments
1
1992
400
0.010
Why?
Antigens, CD
1
1991
341
0.010
Why?
Liver Cirrhosis
1
1991
162
0.010
Why?
Polymers
1
1993
315
0.010
Why?
Cell Line, Transformed
1
1989
98
0.000
Why?
Binding, Competitive
1
1989
97
0.000
Why?
Patient Care Team
1
1992
325
0.000
Why?
Freeze Drying
1
1988
15
0.000
Why?
Self Administration
1
1988
46
0.000
Why?
Incidence
1
1992
1226
0.000
Why?
Blood Cells
1
1987
16
0.000
Why?
Killer Cells, Natural
1
1989
214
0.000
Why?
Pilot Projects
1
1991
913
0.000
Why?
Infant, Newborn
1
1991
1281
0.000
Why?
Neoplasms
1
1996
1239
0.000
Why?
B-Lymphocytes
1
1989
548
0.000
Why?
Hepatitis delta Antigens
1
1985
2
0.000
Why?
Homosexuality
1
1985
6
0.000
Why?
Afghanistan
1
1985
11
0.000
Why?
Hepatitis B Surface Antigens
1
1985
17
0.000
Why?
Retroviridae Infections
1
1985
12
0.000
Why?
Epidemiologic Methods
1
1985
64
0.000
Why?
Fibrinogen
1
1985
31
0.000
Why?
Molecular Weight
1
1984
183
0.000
Why?
Hepatitis B virus
1
1984
13
0.000
Why?
Cells, Cultured
1
1987
2088
0.000
Why?
Prisoners
1
1985
151
0.000
Why?
Genetic Vectors
1
1989
807
0.000
Why?
Phorbol Esters
1
1982
4
0.000
Why?
Phorbol 12,13-Dibutyrate
1
1982
5
0.000
Why?
Peroxides
1
1982
11
0.000
Why?
Neuraminidase
1
1982
43
0.000
Why?
Carrier Proteins
1
1982
696
0.000
Why?
Brettler's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (320)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_